Be part of the knowledge - Prova Education

Medical News

eurekalert.org
04/14/2021
Medical News
Diet Rich in Animal Foods, Alcohol, & Sugar Linked to 'Inflammatory' Gut Micr...
Read more
tsukuba.ac.jp
04/14/2021
Medical News
Myositis-Specific Autoreactive T Cells Are Pathogenic for Dermatomyositis
Read more
bmcpediatr.biomedcentral.com
04/14/2021
Medical News
Targeting Human Milk Fortification to Improve Very Preterm Infant Growth & Br...
Read more

Popular

- Diana Shechtman, OD, FAAO
  Peer
- Mark T. Dunbar, OD, FAAO
  Peer
2
CME/CE
Time Is Vision: The Critical Role of Early Diagnosis and Referral in Neovascular AMD and RVO
Time Is Vision: The Critical Role of Early Diagnosis and Referral in Neovascular AMD and RVO
0.25 credits
Time Is Vision: The Critical Role of Early Diagnosis and Referral in Neovascu...
0.25 credits
- Peter K. Kaiser, MD
  Peer
- Dante J. Pieramici, MD
  Peer
2
CME/CE
Neovascular AMD and RVO: Distinguishing the Differential
Neovascular AMD and RVO: Distinguishing the Differential
0.25 credits
Neovascular AMD and RVO: Distinguishing the Differential
0.25 credits
- Julia Haller, MD
  Peer
3
CME/CE
Time Is Vision: Improving Your Diagnostic Skills
Time Is Vision: Improving Your Diagnostic Skills
0.25 credits
Time Is Vision: Improving Your Diagnostic Skills
0.25 credits
- Diana V. Do, MD
  Peer
- Julia Haller, MD
  Peer
- Rishi P. Singh, MD
  Peer
1
CME/CE
Optimizing Vision Outcomes in nAMD
Optimizing Vision Outcomes in nAMD
0.25 credits
Optimizing Vision Outcomes in nAMD
0.25 credits
- Charles Wykoff, MD, PhD
  Peer
1
CME/CE
Seeing Eye to Eye: Case Series on Treatment Strategies for Neovascular AMD
Seeing Eye to Eye: Case Series on Treatment Strategies for Neovascular AMD
0.25 credits
Seeing Eye to Eye: Case Series on Treatment Strategies for Neovascular AMD
0.25 credits
- Michael S. Ip, MD
  Peer
- Christina Y. Weng, MD, MBA
  Peer
2
CME/CE
Time Is Vision: Early Recognition and Management of Neovascular AMD and RVO
Time Is Vision: Early Recognition and Management of Neovascular AMD and RVO
0.25 credits
Time Is Vision: Early Recognition and Management of Neovascular AMD and RVO
0.25 credits
4
Video Library
3D Animation of What You Need to Know About Pharmacovigilance in Novel Hemophilia A Treatment
3D Animation of What You Need to Know About Pharmacovigilance in Novel Hemophilia A Treatment
3D Animation of What You Need to Know About Pharmacovigilance in Novel Hemoph...
- Peter Schmid, FRCP, MD, PhD
  Peer
- Javier Cortes, MD, PhD
  Peer
2
CME/CE
Keeping Pace in Women’s Cancers: Updates in Triple-Negative Breast Cancer
Keeping Pace in Women’s Cancers: Updates in Triple-Negative Breast Cancer
0.25 credits
Keeping Pace in Women’s Cancers: Updates in Triple-Negative Breast Cancer
0.25 credits

CME/CE

- Shannon L. Meeks, MD
  Peer
- Jonathan C. Roberts, MD
  Peer
2
CME/CE
Practical Guidance for Surveillance and Reporting in Hemophilia A
Practical Guidance for Surveillance and Reporting in Hemophilia A
0.25 credits
Practical Guidance for Surveillance and Reporting in Hemophilia A
0.25 credits
- Emily Chew, MD
  Peer
- Neil Bressler, MD
  Peer
- Joseph M. Coney, MD
  Peer
- Steven Ferrucci, OD, FAAO
  Peer
2
CME/CE
nAMD and RVO: Understanding the Impact on Patient Lives and the Need for Timely Diagnosis and Referral
nAMD and RVO: Understanding the Impact on Patient Lives and the Need for Timely Diagnosis and Referral
0.25 credits
nAMD and RVO: Understanding the Impact on Patient Lives and the Need for Time...
0.25 credits
- Edward J. Mayeaux, Jr., MD, DABFP, FAAFP
  Peer
- Paul P. Doghramji, MD, FAAFP
  Peer
1
CME/CE
Overcoming Barriers to Young Adult Vaccination: A Call to Action for Frontline Providers
Overcoming Barriers to Young Adult Vaccination: A Call to Action for Frontline Providers
0.25 credits
Overcoming Barriers to Young Adult Vaccination: A Call to Action for Frontlin...
0.25 credits
- Peter Schmid, FRCP, MD, PhD
  Peer
- Javier Cortes, MD, PhD
  Peer
1
CME/CE
Novedades sobre el cáncer femenino: Avances en el cáncer de mama triple negativo
Novedades sobre el cáncer femenino: Avances en el cáncer de mama triple negativo
0.25 credits
Novedades sobre el cáncer femenino: Avances en el cáncer de mama triple negativo
0.25 credits
- Neilanjan Nandi, MD
  Peer
- Russell D. Cohen, MD, FACG, AGAF
  Peer
1
CME/CE
New Viewpoints in the Management of IBD
New Viewpoints in the Management of IBD
0.25 credits
New Viewpoints in the Management of IBD
0.25 credits
- Charles E. Geyer, Jr., MD, FACP
  Peer
- Hope S. Rugo, MD
  Peer
1
CME/CE
Evolving Strategies in the Management of HER2-Positive Early-Stage Breast Cancer
Evolving Strategies in the Management of HER2-Positive Early-Stage Breast Cancer
0.25 credits
Evolving Strategies in the Management of HER2-Positive Early-Stage Breast Cancer
0.25 credits

Clinical Practice

- Shannon L. Meeks, MD
  Peer
- Cindy Leissinger, MD
  Peer
2
CME/CE
What You Need to Know About Pharmacovigilance in Novel Hemophilia A Treatment
What You Need to Know About Pharmacovigilance in Novel Hemophilia A Treatment
0.25 credits
What You Need to Know About Pharmacovigilance in Novel Hemophilia A Treatment
0.25 credits
- Neil Bressler, MD
  Peer
0
CME/CE
Take Control of Wet AMD
Take Control of Wet AMD
Take Control of Wet AMD
- Neilanjan Nandi, MD
  Peer
- Sunanda Kane, MD, MSPH, AGAF
  Peer
1
CME/CE
Case Challenges in the Management of IBD
Case Challenges in the Management of IBD
0.25 credits
Case Challenges in the Management of IBD
0.25 credits
- Joel L. Cohen, MD
  Peer
- Jason D. Bloom, MD
  Peer
0
CME/CE
Neuromodulator Dosing for the Upper Face
Neuromodulator Dosing for the Upper Face
0.25 credits
Neuromodulator Dosing for the Upper Face
0.25 credits
- Patricia K. Coyle, MD
  Peer
- Jiwon Oh, MD
  Peer
2
CME/CE
Initial and Subsequent DMT Choices in the Management of Multiple Sclerosis
Initial and Subsequent DMT Choices in the Management of Multiple Sclerosis
0.25 credits
Initial and Subsequent DMT Choices in the Management of Multiple Sclerosis
0.25 credits
- Andrew Alexis, MD, MPH
  Peer
- Linda Stein Gold, MD
  Peer
0
CME/CE
Advancing ACNE Care: Applying Current Knowledge of Patient Needs and Emerging Evidence to Improve Outcomes
Advancing ACNE Care: Applying Current Knowledge of Patient Needs and Emerging Evidence to Improve Outcomes
0.25 credits
Advancing ACNE Care: Applying Current Knowledge of Patient Needs and Emerging...
0.25 credits

Programs

- Neilanjan Nandi, MD
  Peer
- Gary R. Lichtenstein, MD, FACG, FACP, AGAF
  Peer
2
CME/CE
Achieving Long-Term Success in the Management of IBD
Achieving Long-Term Success in the Management of IBD
0.25 credits
Achieving Long-Term Success in the Management of IBD
0.25 credits
- Brendan J. Canning, PhD
  Peer
- Peter Dicpinigaitis, MD
  Peer
1
$Diagnosis and Management of Unexplained or Refractory Chronic Cough$ $Diagnosis and Management of Unexplained or Refractory Chronic Cough$
CME/CE
0.25 credits
Diagnosis and Management of Unexplained or Refractory
Chronic Cough
0.25 credits
- Marwan Noel Sabbagh, MD, FAAN, CCRI
  Peer
- Alireza Atri, MD, PhD
  Peer
7
CME/CE
New Horizons in Alzheimer’s Disease
New Horizons in Alzheimer’s Disease
0.25 credits
New Horizons in Alzheimer’s Disease
0.25 credits
- Alvin F. Wells, MD, PhD
  Peer
6
CME/CE
Elaine Can’t Miss Another Game: Managing Osteoarthritis Pain in Vulnerable Populations
Elaine Can’t Miss Another Game: Managing Osteoarthritis Pain in Vulnerable Populations
0.25 credits
Elaine Can’t Miss Another Game: Managing Osteoarthritis Pain in Vulnerable Po...
0.25 credits
- Edward Chu, MD
  Peer
- Michael J. Overman, MD
  Peer
7
CME/CE
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer
0.25 credits
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic...
0.25 credits
- Brendan J. Canning, PhD
  Peer
- Peter Dicpinigaitis, MD
  Peer
9
CME/CE
Opening a New Chapter on the Diagnosis and Management of Unexplained Chronic Cough
Opening a New Chapter on the Diagnosis and Management of Unexplained Chronic Cough
0.25 credits
Opening a New Chapter on the Diagnosis and Management of Unexplained Chronic ...
0.25 credits